.png){kind=icon}
.png){kind=icon}
Return
Therapeutic options for elderly patients with advanced non-small cell lung cancer
.png){kind=icon}
PRE
AI
E
A
A
DOI：10.1016/j.ctrv.2008.10.008.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the Current management of elderly patients with advanced non-small cell lung cancer. (C) 2008 Elsevier Ltd. All rights reserved.
Keywords:
Non-small cell lung cancer
NSCLC
Elderly
Treatment
Journal
IF:
10.5
Papers:
2.8K
Citations:
1.3W
Organization
Cited Papers